When an Inhibitor Promotes Activity

In a recent issue of Chemistry & Biology, Tropak et al. reported a high-throughput screening assay to identify β-hexosaminidase inhibitors that act as pharmacological chaperones and are potential drug candidates for the treatment of Tay-Sachs disease.